Cardiovascular disease (general) Clinical Trials in Redmond, WA
As of June 2026, 2 paid clinical trials are recruiting for Cardiovascular disease (general) in Redmond, Washington. Recruiting Cardiovascular disease (general) studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Redmond
Filter results
2 clinical trials for Cardiovascular disease (general)
·Clear filters·↓ Download CSVA Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
About research studies in Redmond
Redmond has approximately 14 recruiting research studies across a wide range of therapeutic areas. Washington hosts Fred Hutchinson Cancer Center, UW Medicine, and Seattle Children's — widely recognized for leadership in bone marrow transplantation, immunotherapy, and infectious disease research.
Top Research Study Locations in Redmond
Researchers run research studies in Redmond, WA at 5 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Eastside Research Associates | Atherosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD), COVID-19 SARS-CoV-2 Infection | 8 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Eastside Research Associates, LLC dba Era Health Research | Atherosclerosis | 1 |
| Era Health Research | Obesity or Overweight, Type 2 Diabetes Mellitus | 1 |
| Redmond Eye Clinic | Myopia | 1 |
Active & Upcoming Studies in Redmond (2026)
Recruiting trials in Redmond grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Vaccines (2 active studies)
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) · Phase 3 · Merck Sharp & Dohme LLC
Diabetes & metabolic (2 active studies)
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · Hoffmann-La Roche
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide · Phase 2 · Eli Lilly and Company
Cardiovascular (2 active studies)
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin · Phase 3 · AstraZeneca
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) · Phase 3 · Anthos Therapeutics, Inc.
Mental health & behavior (1 active study)
- A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse · Phase 2 · Eli Lilly and Company
Common conditions studied in Redmond
- Atherosclerosis (2 active studies). Recruiting Atherosclerosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Atherosclerotic Cardiovascular Disease (ASCVD) (1 active study). Recruiting Atherosclerotic Cardiovascular Disease (ASCVD) studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Atrial Fibrillation (AF) (1 active study). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
- COVID-19 SARS-CoV-2 Infection (1 active study). COVID-19 research evaluates next-generation vaccines, antivirals, and therapies for long COVID.
- Cardiovascular Disease (1 active study). Recruiting Cardiovascular Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Cardiovascular Diseases (1 active study). Recruiting Cardiovascular Diseases studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Redmond
- Eli Lilly and Company
- AstraZeneca
- Anthos Therapeutics, Inc.
- CooperVision, Inc.
- Genentech, Inc.
Local regulations and guidelines
Clinical trials in Washington are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Studies in Washington must also comply with the My Health My Data Act, which adds consumer-health-data protections on top of federal HIPAA requirements.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Redmond. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Redmond
Hipa.ai aggregates every recruiting study in Redmond from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Redmond?
There are approximately 14 recruiting clinical trials in Redmond, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Redmond pay participants?
Most recruiting trials in Redmond compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Redmond?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Redmond?
The most common conditions under active study in Redmond include Atherosclerosis (2), Atherosclerotic Cardiovascular Disease (ASCVD) (1), Atrial Fibrillation (AF) (1), COVID-19 SARS-CoV-2 Infection (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Redmond?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Redmond on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Redmond?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Redmond?
Recruiting research sites in Redmond include Eastside Research Associates, Anthos Investigative, Eastside Research Associates, LLC dba Era Health Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Redmond right now?
The largest active categories in Redmond are Vaccines (2), Diabetes & metabolic (2), Cardiovascular (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.